5-HT RBD REM Sleep Behavior Disorder

计划入组 66 人 · 首次发布于 2024 年 6 月 21 日

A Clinical Study of HT-101 and HT-102 in Patients With Chronic Hepatitis B Virus Infection

计划入组 60 人 · 首次发布于 2025 年 11 月 24 日

A Clinical Study of HT-101 and/or HT-102 in Patients With Chronic Hepatitis B Virus Infection

计划入组 86 人 · 首次发布于 2025 年 9 月 19 日

5-HT1B/D antagonist (SB)

RQ-00310941

B-HT-920

Center 5

United States

AB&B BIO-TECH-B

Hangzhou MTR Line 5 Corporation Limited

China

Enveric Biosciences Publishes Breakthrough Research on Microbial Bioproduction of Neuropsychiatric Compounds

Enveric Biosciences Secures Patent Victory as AbbVie Withdraws Challenge Following $1.2 Billion Gilgamesh Acquisition

Enveric Biosciences Secures Fourth Patent for Non-Hallucinogenic Neuroplastogenic Drug Candidates